enVVeno Medical (NASDAQ:NVNO – Get Free Report) issued its quarterly earnings data on Thursday. enVVeno Medical Stock PerformanceNVNO traded up $0.13 during midday trading on Thursday, hitting $10.53. LADENBURG THALM/SH SH upgraded enVVeno Medical from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. enVVeno Medical Company Profile(Get Free Report)enVVeno Medical, Inc is a clinical?stage medical device company focused on the development and commercialization of subcutaneous vascular access systems for patients requiring repeated or long?term intravenous therapy. Further ReadingReceive News & Ratings for enVVeno Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for enVVeno Medical and related companies with MarketBeat.com's FREE daily email newsletter.